Antibody from Tanzanian woman suppresses almost all tested HIV variants including resistant viruses in pre-clinical study
Antibodies that ‘wait and pounce’ generated by promising HIV vaccine candidate
Revolutionary HIV vaccine that ‘trains’ the immune system passes its first hurdle
Do broadly neutralising antibodies really have a future in treating HIV?
The paediatric drug pipeline should include improvements to current HIV treatment, long-acting formulations and antibodies
Giving antibodies to prevent vertical transmission in Africa would be cost-effective or even save money, study finds
HIV vaccines and immunotherapies “would be further along” if they had the resources of COVID-19, says leading antibody researcher
Where next for HIV vaccines and antibody therapies?
Antibody-based PrEP did not stop most types of HIV – but is still hailed as a ‘game changer’
